Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00932373 |
|---|---|
| Brief Title: | A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen |
| First Submitted : | June 30, 2009 |
| First Submitted that Met QC Criteria : | July 2, 2009 |
| First Posted : | July 3, 2009 (Estimate) |
| Results First Submitted : | July 1, 2015 |
| Results First Submitted that Met QC Criteria : | July 2, 2015 |
| Results First Posted : | July 30, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 13, 2015 |
| Last Update Posted : | August 26, 2015 (Estimate) |